NO152892C - Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon. - Google Patents

Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.

Info

Publication number
NO152892C
NO152892C NO802030A NO802030A NO152892C NO 152892 C NO152892 C NO 152892C NO 802030 A NO802030 A NO 802030A NO 802030 A NO802030 A NO 802030A NO 152892 C NO152892 C NO 152892C
Authority
NO
Norway
Prior art keywords
procedure
preparation
water
magic acid
neutralizing
Prior art date
Application number
NO802030A
Other languages
English (en)
Other versions
NO152892B (no
NO802030L (no
Inventor
Eva Kristina Byroed
John Albert Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO802030L publication Critical patent/NO802030L/no
Publication of NO152892B publication Critical patent/NO152892B/no
Publication of NO152892C publication Critical patent/NO152892C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO802030A 1979-07-09 1980-07-04 Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon. NO152892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Publications (3)

Publication Number Publication Date
NO802030L NO802030L (no) 1981-01-12
NO152892B NO152892B (no) 1985-09-02
NO152892C true NO152892C (no) 1985-12-11

Family

ID=20338481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802030A NO152892C (no) 1979-07-09 1980-07-04 Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.

Country Status (21)

Country Link
US (1) US4465667A (no)
EP (1) EP0022429B1 (no)
JP (1) JPS5618922A (no)
AR (1) AR228854A1 (no)
AT (1) ATE1968T1 (no)
AU (1) AU535403B2 (no)
CA (1) CA1146860A (no)
DE (1) DE3061333D1 (no)
DK (1) DK154265C (no)
ES (1) ES493187A0 (no)
FI (1) FI71058C (no)
GR (1) GR69623B (no)
HK (1) HK43484A (no)
IE (1) IE50141B1 (no)
MY (1) MY8500445A (no)
NO (1) NO152892C (no)
NZ (1) NZ194165A (no)
PH (2) PH16372A (no)
PT (1) PT71503B (no)
SE (1) SE7905972L (no)
SG (1) SG9384G (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0642001B2 (ja) * 1983-10-20 1994-06-01 セイコーエプソン株式会社 合成樹脂製レンズ
JPS6486101A (en) * 1987-06-18 1989-03-30 Toray Industries Production of antireflecting article
JPH0696536B2 (ja) * 1988-02-26 1994-11-30 佐藤製薬株式会社 制酸剤含有内用懸濁液
US5158770A (en) * 1989-12-29 1992-10-27 Freund Industrial Co., Ltd. Aqueous solution containing ginkgo leaf extract
AU657882B2 (en) * 1993-03-26 1995-03-23 Wallace Victor Wind Improvements in or relating to the treatment of diarrhoea
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
SE509300C2 (sv) * 1995-02-02 1999-01-11 Sueddeutsche Kalkstickstoff Katjoniskt dispergerade aluminiumhydroxiduppslamningar
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6187317B1 (en) 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
DK1523984T3 (da) * 2003-10-13 2007-03-26 Zoser B Salama Farmaceutisk sammensætning indeholdende oxoplatin og dettes salte
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211745A (en) * 1940-04-18 1940-08-13 Alba Pharmaceutical Company In Compound of aluminum hydroxide and process of making the same
US2999790A (en) * 1959-08-24 1961-09-12 Sterling Drug Inc Stable aluminum hydroxide suspension
US3239416A (en) * 1963-05-29 1966-03-08 Armour Pharma Aluminum hydroxide-metal hydroxide antacid and process of making the same
US3272704A (en) * 1963-06-06 1966-09-13 Armour Pharma Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same
US3499963A (en) * 1964-04-15 1970-03-10 Armour Pharma Codried aluminum hydroxide-aluminum chelate antacid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate
IL32020A (en) * 1968-04-18 1972-11-28 Brown G Antacid compositions
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
GB1414121A (en) * 1971-09-15 1975-11-19 Smith W J Antacid composition and its preparation
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom

Also Published As

Publication number Publication date
CA1146860A (en) 1983-05-24
PT71503B (en) 1981-12-11
DK290080A (da) 1981-01-10
EP0022429B1 (en) 1982-12-15
PT71503A (en) 1980-08-01
HK43484A (en) 1984-05-25
AU5973480A (en) 1981-01-15
NO152892B (no) 1985-09-02
FI802139A (fi) 1981-01-10
FI71058B (fi) 1986-08-14
SE7905972L (sv) 1981-01-10
JPS5618922A (en) 1981-02-23
DE3061333D1 (en) 1983-01-20
AR228854A1 (es) 1983-04-29
MY8500445A (en) 1985-12-31
NZ194165A (en) 1984-07-06
US4465667A (en) 1984-08-14
PH16372A (en) 1983-09-14
JPS6411008B2 (no) 1989-02-23
ES8106835A1 (es) 1981-09-01
GR69623B (no) 1982-07-06
DK154265B (da) 1988-10-31
IE50141B1 (en) 1986-02-19
PH16705A (en) 1984-01-20
AU535403B2 (en) 1984-03-22
NO802030L (no) 1981-01-12
IE801402L (en) 1981-01-09
ATE1968T1 (de) 1982-12-15
ES493187A0 (es) 1981-09-01
FI71058C (fi) 1986-11-24
EP0022429A1 (en) 1981-01-14
SG9384G (en) 1985-02-15
DK154265C (da) 1989-03-28

Similar Documents

Publication Publication Date Title
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO802576L (no) Fremgangsmaate til fremstillingav 3,4-disubstituerte-1,2,5-tiadiazol-1-oksyder og -1,1-dioksyder
NO157048C (no) Fremgangsmaate til fremstilling av en tablett.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO813252L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporinderivater.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO803591L (no) Fremgangsmaate for fremstilling av fiskemel.
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
NO152892C (no) Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO149630C (no) Analogifremgangsmaate til fremstilling av anti-psoriatiske 1,8-dihydroksy-10-acyl-9-antroner
NO800345L (no) Fremgangsmaate til fremstilling av syntetisk romboedrisk manetitt
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO793103L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.